Cargando…
The role of pyruvate kinase M2 in anticancer therapeutic treatments
Cancer cells are characterized by a high glycolytic rate, which leads to energy regeneration and anabolic metabolism; a consequence of this is the abnormal expression of pyruvate kinase isoenzyme M2 (PKM2). Multiple studies have demonstrated that the expression levels of PKM2 are upregulated in nume...
Autores principales: | Su, Qiongli, Luo, Shengping, Tan, Qiuhong, Deng, Jun, Zhou, Sichun, Peng, Mei, Tao, Ting, Yang, Xiaoping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6865080/ https://www.ncbi.nlm.nih.gov/pubmed/31788038 http://dx.doi.org/10.3892/ol.2019.10948 |
Ejemplares similares
-
The role of Clusterin in cancer metastasis
por: Peng, Mei, et al.
Publicado: (2019) -
Down‐regulation of PKM2 enhances anticancer efficiency of THP on bladder cancer
por: Su, Qiongli, et al.
Publicado: (2018) -
Phenformin alone or combined with gefitinib inhibits bladder cancer via AMPK and EGFR pathways
por: Huang, Yanjun, et al.
Publicado: (2018) -
The molecular mechanisms of LncRNA-correlated PKM2 in cancer metabolism
por: Tao, Ting, et al.
Publicado: (2019) -
Novel application of metformin combined with targeted drugs on anticancer treatment
por: Deng, Jun, et al.
Publicado: (2018)